Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Medical Industry Today.
Press releases published on July 18, 2025

US Wearable Technology market to grow at a CAGR of 15.4%: Wissen Research
Sheridan, July 18, 2025 (GLOBE NEWSWIRE) -- According to the latest global wearable market report published by Wissen Research, the US wearable technology market was valued at USD 24 billion in 2024 and is expected to grow at a CAGR of 15.4% during the …

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NOVATO, Calif., July 18, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of …

HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock
NEW YORK and VIENNA, July 18, 2025 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”), a clinical-stage biopharmaceutical company developing next-generation immunotherapeutics for the treatment of cancer and serious infectious diseases, …

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., July 18, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, effective as of July 17, 2025, the Compensation Committee of the …

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
SOUTH SAN FRANCISCO, Calif., July 18, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on July 16, 2025 it granted stock options to purchase an aggregate of 131,683 shares of common stock and 88,755 restricted stock …

Optimum Wound Care Center Details Multidisciplinary Approach to Healing Chronic and Complex Wounds in Louisville
Louisville clinic unveils care model blending diagnostics, advanced therapies, and education to boost healing of diabetic ulcers and pressure injuries. LOUISVILLE, KY, UNITED STATES, July 18, 2025 /EINPresswire.com/ -- Chronic wounds can be difficult to …

Tamara Moss, MD, FAAD of Moss Dermatology Awarded As NY Top Doc
NY Top Docs has reviewed and approved dermatologist Tamara Moss, MD, FAAD of Moss Dermatology based on merit. FOREST HILLS, NY, UNITED STATES, July 18, 2025 /EINPresswire.com/ -- NY Top Docs has reviewed and approved dermatologist Tamara Moss, MD, FAAD …

What’s Next for the Healthcare Market: Innovation, Growth Trajectories, and Industry Transformations
Healthcare Market expansion continues, climbing from USD 13695.28 Billion in 2025 to USD 22347.74 Billion by 2033, fueled by a CAGR of 6.9%. PUNE, MAHARASHTRA, INDIA, July 18, 2025 /EINPresswire.com/ -- Global Healthcare Market Report: Growth, …

6th TimePie Longevity Forum: A Global Gateway to China’s 1.4 Billion Anti-Aging Opportunities
From science to solution, from policy to practice. SINGAPORE, July 18, 2025 /EINPresswire.com/ -- As China’s population ages rapidly, the development of the longevity industry has been prioritized to the level of national strategy since 2024. To …

Human Appeal USA Mobilizes Relief and Volunteer Event for Texas Flood Victims
DALLAS, July 18, 2025 (GLOBE NEWSWIRE) -- In the wake of devastating floods across Texas, including persistent overflow from the Guadalupe River, Dallas-based nonprofit Human Appeal USA is taking action to support affected families with both on-the-ground …

Tevogen.AI Receives International Patent Publication for AI Technology Predicting Immunologically Active Peptides
WARREN, N.J., July 18, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) announced today that the International Bureau of the World Intellectual Property Organization (WIPO) has published its international patent …

Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
Company announcement – No. 17 / 2025 Zealand Pharma major shareholder announcement: Van Herk Investments B.V. Copenhagen, Denmark, July 18, 2025 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the …

Caregiver’s Compass – A New Book Helping Caregivers Get Through Dementia with Confidence
Caregiver’s Compass, by Alex J. Buison, offers real-life stories, expert advice, and practical tools for caregivers supporting loved ones with dementia. LAS VEGAS, NV, UNITED STATES, July 17, 2025 /EINPresswire.com/ -- Caring for a loved one with …

European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
STAMFORD, Conn., July 18, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc., a healthcare company of Merck, announced today that the European Commission (EC) granted conditional marketing authorization for EZMEKLY® (mirdametinib) for the treatment of …

European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
STAMFORD, Conn., July 18, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany, announced today that the European Commission (EC) granted conditional marketing authorization for EZMEKLY® ( …

Hapbee Reports First-Ever Quarterly Profit in Q2 2025 and Achieves Third Consecutive Quarter of Growth
VANCOUVER, British Columbia, July 18, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies Inc. (TSXV: HAPB | OTCQB: HAPBF), a wearable wellness technology company and the pioneer of bio-streaming products, today announced its unaudited financial results for the …

Muscle Gain & Strength Supplements: How CrazyBulk Muscle Building Supplements Boost Strength and Maximize Muscle Performance Fast
New York City, NY, July 18, 2025 (GLOBE NEWSWIRE) -- In the ever-evolving world of muscle building, performance, and strength enhancement, CrazyBulk has emerged as the name reshaping the conversation around legal supplements. As fitness communities move …

EURneffy® (adrenaline nasal spray) Approved in the U.K. as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)
EURneffy (neffy® in the U.S.) offers a new delivery method for adrenaline in the U.K. for adults and children (>30 kg) living with severe allergic reactions ALK-Abelló A/S, which owns the rights to market EURneffy in the U.K., expects availability in late …

Connect Biopharma to Participate in the BTIG Virtual Biotechnology Conference
SAN DIEGO, July 18, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect”, or the “Company”), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory …

Senti Bio Appoints Entrepreneurial Leader and Investor, Bryan Baum, to Board of Directors
SOUTH SAN FRANCISCO, Calif., July 18, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene …